Minerva medicaPub Date : 2023-10-01Epub Date: 2021-12-03DOI: 10.23736/S0026-4806.21.07856-3
Jing Guo, Lu Li, Qingtao Ren
{"title":"Safety evaluation of celecoxib in patients with ulcerative colitis in remission stage with arthritis.","authors":"Jing Guo, Lu Li, Qingtao Ren","doi":"10.23736/S0026-4806.21.07856-3","DOIUrl":"10.23736/S0026-4806.21.07856-3","url":null,"abstract":"","PeriodicalId":18671,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":4.7,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39686725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Minerva medicaPub Date : 2023-10-01Epub Date: 2023-03-13DOI: 10.23736/S0026-4806.23.08428-8
Fadi Abu Baker, Yana Davidov, Areil Israel, Ilan Green, Randa Taher, Ziv Ben Ari, Saif Abu Mouch
{"title":"Chronic hepatitis B infection and diabetes mellitus: a double liver trouble?","authors":"Fadi Abu Baker, Yana Davidov, Areil Israel, Ilan Green, Randa Taher, Ziv Ben Ari, Saif Abu Mouch","doi":"10.23736/S0026-4806.23.08428-8","DOIUrl":"10.23736/S0026-4806.23.08428-8","url":null,"abstract":"<p><strong>Background: </strong>Concomitant Diabetes mellitus (DM) is commonly recognized in patients with chronic hepatitis B (CHB) infection, although its impact on liver-related outcomes remains controversial. We aimed to evaluate the effect of DM on the course, management and outcome of patients with CHB.</p><p><strong>Methods: </strong>We performed a large retrospective cohort study utilizing the Leumit-Health-Service (LHS) database. We reviewed electronic reports of 692106 LHS members from different ethnicities and districts in Israel from 2000-2019 and included patients with CHB diagnosis based on ICD-9-CM codes and supportive serology results. These were divided into two cohorts of patients with CHB and DM (CHD-DM) (N.=252) and those with CHB without DM (N.=964). Clinical parameters, treatment figures and patients' outcomes were compared and multiple regression models and Cox regression analysis were performed to investigate the association between DM and cirrhosis/HCC risk in CHB patients.</p><p><strong>Results: </strong>CHD-DM patients were significantly older (49.2±10.9 vs. 37.9±14, P<0.001), and had higher rates of obesity (BMI>30) and NAFLD (47.2% vs. 23.1%, and 27% vs. 12.6%, P<0.001, respectively). Both groups had a predominance of inactive carrier (HBeAg negative infection) state, but the HBeAg seroconversion rate was significantly lower in the CHB-DM group (25% vs. 45.7%; P<0.01). Multivariable Cox regression analysis showed that DM was independently associated with increased cirrhosis risk (HR 2.63; P=0.002). Older age, advanced fibrosis and DM were associated with HCC, but DM did not reach significance (HR 1.4; P=0.12) possibly due to the small number of HCC cases.</p><p><strong>Conclusions: </strong>Concomitant DM in CHB patients was significantly and independently associated with cirrhosis and possibly with increased risk of HCC.</p>","PeriodicalId":18671,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":4.7,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9091348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Minerva medicaPub Date : 2023-10-01Epub Date: 2021-03-12DOI: 10.23736/S0026-4806.21.07458-9
Graziella Bonetti, Gianpaolo Chitoni, Alessandra Bettinardi, Gianluca Borrelli, Gianfranco Fiordalisi, Antonio Marino, Annamaria Menolfi, Roberta Volpi, Filippo Manelli, Maria S Cotelli
{"title":"Can natural immunity partially replace vaccine against SARS-COV2 infection? A small single center study.","authors":"Graziella Bonetti, Gianpaolo Chitoni, Alessandra Bettinardi, Gianluca Borrelli, Gianfranco Fiordalisi, Antonio Marino, Annamaria Menolfi, Roberta Volpi, Filippo Manelli, Maria S Cotelli","doi":"10.23736/S0026-4806.21.07458-9","DOIUrl":"10.23736/S0026-4806.21.07458-9","url":null,"abstract":"","PeriodicalId":18671,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":4.7,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25468251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Minerva medicaPub Date : 2023-10-01Epub Date: 2021-12-03DOI: 10.23736/S0026-4806.21.07902-7
Hua Li, Yong Liang, Chunmei Yang, Keru Zhang, Miao Tian, Bin Chen, Ji Xu
{"title":"Effect of early bedside rehabilitation intervention on limb function recovery in patients with stroke.","authors":"Hua Li, Yong Liang, Chunmei Yang, Keru Zhang, Miao Tian, Bin Chen, Ji Xu","doi":"10.23736/S0026-4806.21.07902-7","DOIUrl":"10.23736/S0026-4806.21.07902-7","url":null,"abstract":"","PeriodicalId":18671,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":4.7,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39686726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Minerva medicaPub Date : 2023-10-01Epub Date: 2020-06-02DOI: 10.23736/S0026-4806.20.06652-5
Ruixue Xia, Na Fang, Yanjie Yang, Feng Xu, Lingge Zhang, Shaoping Ji
{"title":"PM2.5 promotes apoptosis of alveolar epithelial cells via targeting ROS/p38 signaling pathway and thus leads to emphysema in mice.","authors":"Ruixue Xia, Na Fang, Yanjie Yang, Feng Xu, Lingge Zhang, Shaoping Ji","doi":"10.23736/S0026-4806.20.06652-5","DOIUrl":"10.23736/S0026-4806.20.06652-5","url":null,"abstract":"<p><strong>Background: </strong>The aim of this study was to uncover the ability of PM<inf>2.5</inf> exposure to induce apoptosis in alveolar epithelial cells by stimulating excessive production of reactive oxygen species (ROS), thus activating p38 to result in emphysema in mice.</p><p><strong>Methods: </strong>Male BALB/c mice with 6-8-week-old were exposed to 200 TPM mg/L PM<inf>2.5</inf> for 12 weeks. Lung tissues of mice were harvested after sacrifice. Hematoxylin and eosin staining was conducted for observing alveolar structure change. Protein levels of p-p38 and p38, as well as ROS level in mouse liver tissues were determined. A549 cells were exposed to different doses of PM<inf>2.5</inf>, followed by ROS detection, protein level detection of p-p38 and p38, and apoptosis determination. After transfection of si-p38, protein level of clv-caspase3 and apoptotic rate in PM<inf>2.5</inf>-exposed A549 cells were assessed.</p><p><strong>Results: </strong>After 12-week exposure to PM<inf>2.5</inf>, enlarged alveolar space, elevated ROS level in lung tissues and activated p38 were observed in mice. In PM<inf>2.5</inf>-exposed A549 cells, ROS level, p-p38 expression and apoptotic rate were dose-dependently enhanced. The antioxidant NAC reversed the above changes in PM<inf>2.5</inf>-exposed A549 cells. Silence of p38 reversed the enhanced clv-claspase3 level and apoptotic rate in PM<inf>2.5</inf>-exposed A549 cells.</p><p><strong>Conclusions: </strong>PM<inf>2.5</inf> exposure elevates ROS level in lung tissues, and activates p38, thus leading to apoptosis of alveolar epithelial cells. PM<inf>2.5</inf> finally results in the development of emphysema in mice.</p>","PeriodicalId":18671,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":4.7,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38008542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Minerva medicaPub Date : 2023-10-01Epub Date: 2022-06-07DOI: 10.23736/S0026-4806.22.07579-6
Sara Xuereb, Caroline J Magri, Rachel A Xuereb, Robert G Xuereb, Joseph Galea, Stephen Fava
{"title":"Predictors of subclinical atherosclerosis and microalbuminuria in middle-aged women: a cross-sectional study.","authors":"Sara Xuereb, Caroline J Magri, Rachel A Xuereb, Robert G Xuereb, Joseph Galea, Stephen Fava","doi":"10.23736/S0026-4806.22.07579-6","DOIUrl":"10.23736/S0026-4806.22.07579-6","url":null,"abstract":"BACKGROUND\u0000Cardiovascular disease is of increasing concern in women. The aim was to assess the role of clinical and anthropometric measures in the development of subclinical atherosclerosis.\u0000\u0000\u0000METHODS\u0000A cross-sectional study in 203 Europid females to determine the prevalence of abnormal carotid intima-media thickness (CIMT) and associated clinical parameters.\u0000\u0000\u0000RESULTS\u0000The study population had a mean age of the 38.3±5.4 years, a median body mass index of 29.25 (IQR 25.06-36.11) Kg/m2 and median waist index (WI) of 1.15 (IQR 1.06-1.34). Increased CIMT was present in 169 (83.25%) participants. Linear regression analysis revealed WI to be the sole predictor of increased CIMT (β=24.387, p<0.001). Post-hoc ROC analysis revealed a WI of 1.12 has 62% sensitivity and 53% specificity for predicting increased CIMT (AUC 0.63, 95% CI 0.55-0.72, p=0.016). The median urinary albumincreatinine ratio (ACR) was 4.4mg/g and the prevalence of microalbuminuria was 8.9%; serum triglycerides were the only independent predictor of ACR.\u0000\u0000\u0000CONCLUSIONS\u0000Atherosclerosis, as detected by abnormal CIMT, is very prevalent in middleaged women. Waist index is the major predictor of subclinical atherosclerosis in a contemporary premenopausal female population. A WI of 1.12 exhibits relatively good sensitivity & specificity in predicting the presence of atherosclerosis in this patient population.","PeriodicalId":18671,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":4.7,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45506039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Minerva medicaPub Date : 2023-10-01Epub Date: 2023-03-23DOI: 10.23736/S0026-4806.22.08408-7
Gianni Testino, Luigi C Bottaro, Enzo Andorno, Fabio Bandini, Patrizia Balbinot, Sabrina Beltramini, Simona Bottino, Marta Caltabellotta, Fabio Caputo, Enrica Caviglia, Pierfrancesco Curone, Antonio DI Biagio, Carmelo Gagliano, Nicoletta Gandolfo, Luca Pestarino, Alessandro Rollero, Emanuele Romairone, Lorenzo Sampietro, Enrico Torre, Silvia Zuccarelli, Rinaldo Pellicano
{"title":"Hepatic encephalophathy: management and diagnostic therapeutic assistance path of Ligurian Local Health Company 3 (ASL3).","authors":"Gianni Testino, Luigi C Bottaro, Enzo Andorno, Fabio Bandini, Patrizia Balbinot, Sabrina Beltramini, Simona Bottino, Marta Caltabellotta, Fabio Caputo, Enrica Caviglia, Pierfrancesco Curone, Antonio DI Biagio, Carmelo Gagliano, Nicoletta Gandolfo, Luca Pestarino, Alessandro Rollero, Emanuele Romairone, Lorenzo Sampietro, Enrico Torre, Silvia Zuccarelli, Rinaldo Pellicano","doi":"10.23736/S0026-4806.22.08408-7","DOIUrl":"10.23736/S0026-4806.22.08408-7","url":null,"abstract":"<p><p>Hepatic encephalophathy (HE) is a neuropsychiatric syndrome with a prevalence in the cirrhotic population ranging from 20 to 80%. HE is a cause of inappropriate hospitalization, caregiver burdening and increased social costs. There is need to create dedicated care pathways to better manage patients and support family caregivers. The data used for the preparation of this diagnostic therapeutic assistance path (DTAP) are based on a detailed analysis of the scientific literature published before June 30, 2022 (PubMed, Web of Science, Scopus, Google Scholar). Furthermore, in the process of developing this work, we consulted in particular the guidelines/ position papers of International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN), Italian Association for the Study of the Liver (AISF), European Association for the Study of the Liver (EASL), American Association for the Study of Liver Diseases (AASLD), Italian Society on Alcohol (Società Italiana di Alcologia [SIA]) and other relevant papers. DTAP was created based on the most recent recommendations of the international scientific literature. The present DTAP highlight the need for a multidisciplinary activity integrated with territorial medicine in close connection with caregivers. This guarantees improved therapeutic adherence, hospital readmission reduction, improved quality of life for patients and caregivers and a significant reduction in costs.</p>","PeriodicalId":18671,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":4.7,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9161463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Minerva medicaPub Date : 2023-10-01Epub Date: 2023-06-09DOI: 10.23736/S0026-4806.23.08684-6
Francesco Versaci, Sebastian Kufner, Salvatore Cassese, Michael Joner, Katharina Mayer, Erion Xhepa, Tobias Koch, Jens Wiebe, Tareq Ibrahim, Karl-Ludwig Laugwitz, Heribert Schunkert, Adnan Kastrati, Robert A Byrne, Alessandra Spagnoli, Marco Bernardi, Luigi Spadafora, Giuseppe Biondi-Zoccai
{"title":"Very long-term outlook of acute coronary syndromes after percutaneous coronary intervention with implantation of polymer-free versus durable-polymer new-generation drug-eluting stents.","authors":"Francesco Versaci, Sebastian Kufner, Salvatore Cassese, Michael Joner, Katharina Mayer, Erion Xhepa, Tobias Koch, Jens Wiebe, Tareq Ibrahim, Karl-Ludwig Laugwitz, Heribert Schunkert, Adnan Kastrati, Robert A Byrne, Alessandra Spagnoli, Marco Bernardi, Luigi Spadafora, Giuseppe Biondi-Zoccai","doi":"10.23736/S0026-4806.23.08684-6","DOIUrl":"10.23736/S0026-4806.23.08684-6","url":null,"abstract":"<p><strong>Background: </strong>Detailed long-term follow-up data on patients with acute coronary syndromes (ACS) in general, and those with ST-elevation myocardial infarction (STEMI) in particular, are limited. We aimed to appraise the long-term outlook of patients undergoing percutaneous coronary intervention (PCI) with state-of-the-art coronary stents for STEMI, other types of ACS and stable coronary artery disease (CAD), and also explore the potential beneficial impact of new-generation polymer-free drug-eluting stents (DES) in this setting.</p><p><strong>Methods: </strong>Baseline, procedural and very long-term outcome data on patients undergoing PCI and randomized to implantation of new-generation polymer-free vs. durable polymer DES were systematically collected, explicitly distinguishing subjects with admission diagnosis of STEMI, non-ST-elevation ACS (NSTEACS), and stable CAD. Outcomes of interest included death, myocardial infarction, revascularization (i.e. patient-oriented composite endpoints [POCE]), major adverse cardiac events (MACE), and device-oriented composite endpoints (DOCE).</p><p><strong>Results: </strong>A total of 3002 patients were included, 1770 (59.0%) with stable CAD, 921 (30.7%) with NSTEACS, and 311 (10.4%) with STEMI. At long-term follow-up (7.5±3.1 years), all clinical events were significantly more common in the NSTEACS group and, to a lesser extent, in the stable CAD group (e.g. POCE occurred in, respectively, 637 [44.7%] vs. 964 [37.9%] vs. 133 [31.5%], P<0.001). While these differences were largely attributable to adverse coexisting features in patients with NSTEACS (e.g. advanced age, insulin-dependent diabetes, and extent of CAD), the unfavorable outlook of patients presenting with NSTEACS persisted even after multivariable adjustment including several prognostically relevant factors (hazard ratio [HR] of NSTEACS vs. stable CAD 1.19 [95% confidence interval 1.03-1.38], P=0.016). Notably, even after encompassing all prognostically impactful features, no difference between polymer-free and permanent polymer drug-eluting stents appeared (HR=0.96 [0.84-1.10], P=0.560).</p><p><strong>Conclusions: </strong>Unstable coronary artery disease, especially when presenting without ST-elevation, represents an informative marker of adverse long-term prognosis in current state-of-the-art invasive cardiology practice. Even considering admission diagnosis, and despite of using no polymer, polymer-free DES showed similar results with regards to safety and efficacy when compared with DES with permanent polymer.</p>","PeriodicalId":18671,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":4.7,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9595085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Minerva medicaPub Date : 2023-10-01Epub Date: 2022-02-22DOI: 10.23736/S0026-4806.22.07797-7
Matteo Montorfano, Olivia Leoni, Aida Andreassi, Monica Ludergnani, Francesco Moroni, Marco B Ancona, Giovanni Landoni, Fabio Ciceri, Alberto Zangrillo
{"title":"Chronic anticoagulant treatment and risk of mortality in SARS-Cov2 patients: a large population-based study.","authors":"Matteo Montorfano, Olivia Leoni, Aida Andreassi, Monica Ludergnani, Francesco Moroni, Marco B Ancona, Giovanni Landoni, Fabio Ciceri, Alberto Zangrillo","doi":"10.23736/S0026-4806.22.07797-7","DOIUrl":"10.23736/S0026-4806.22.07797-7","url":null,"abstract":"<p><strong>Background: </strong>Hypercoagulability is often seen in COVID-19 patients and thromboembolic events appear frequent; antithrombotic treatment has been proposed therefore as part of standard treatment for COVID-19. Under these premises, prior-to-infection antithrombotic treatment may have a protective effect with respect to COVID-19 related thromboembolic events. Aim of the present work was to evaluate the impact of prior-to-infection anticoagulant or antiplatelet treatment on COVID-19 outcomes.</p><p><strong>Methods: </strong>Beneficiaries of the Regional Health Service of the Lombardy region of Italy aged ≥40 years with a COVID-19 diagnosis made between February 21<sup>st</sup> and July 18<sup>th</sup>, 2020 were included in the present study. The impact on COVID-19 mortality of pre-existing and chronic therapy with anticoagulant drugs (vitamin-K antagonist or new oral anticoagulants) was evaluated. Analyses were repeated with antiplatelets drugs.</p><p><strong>Results: </strong>Among 79,934 SARS-CoV-2 patients beneficiaries of the Regional Healthcare System of the Lombardy Region who received a diagnosis between February 21<sup>st</sup> and July 18<sup>th</sup>, 2020, chronic pre-existing anticoagulant assumption was present in 6.0% and antiplatelets in 12.7%. The overall unadjusted mortality rate was 20.6%, with male sex, age category and comorbidity burden being significantly associated to increased mortality risk. Anticoagulant chronic treatment was not associated with a reduction in mortality. Similar results were observed when repeating the analyses for pre-existing oral antiplatelet treatment.</p><p><strong>Conclusions: </strong>In a large population-based study evaluating more than 79,000 COVID-19 patients, pre-existing antithrombotic therapy was not associated to a benefit in terms of mortality. Further studies are needed to evaluate the role of antithrombotic therapy as standard treatment among COVID-19 patients.</p>","PeriodicalId":18671,"journal":{"name":"Minerva medica","volume":null,"pages":null},"PeriodicalIF":4.7,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39943177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}